Blisibimod

Modify Date: 2024-04-02 14:36:32

Blisibimod Structure
Blisibimod structure
Common Name Blisibimod
CAS Number 1236126-45-6 Molecular Weight N/A
Density N/A Boiling Point N/A
Molecular Formula N/A Melting Point N/A
MSDS N/A Flash Point N/A

 Use of Blisibimod


Blisibimod (A 623) is a potent and selective tetravalent inhibitor of B-cell activating factor (BAFF). Blisibimod can be used for the research of systemic lupus erythematosus (SLE)[1][2].

 Names

Name Blisibimod

 Blisibimod Biological Activity

Description Blisibimod (A 623) is a potent and selective tetravalent inhibitor of B-cell activating factor (BAFF). Blisibimod can be used for the research of systemic lupus erythematosus (SLE)[1][2].
Related Catalog
In Vitro Blisibimod 以高亲和力阻断所有三种形式的 BAFF[1]。
References

[1]. Merrill JT, et, al. Phase III trial results with blisibimod, a selective inhibitor of B-cell activating factor, in subjects with systemic lupus erythematosus (SLE): results from a randomised, double-blind, placebo-controlled trial. Ann Rheum Dis. 2018 Jun;77(6):883-889.  

[2]. Lenert A, wt, al. Spotlight on blisibimod and its potential in the treatment of systemic lupus erythematosus: evidence to date. Drug Des Devel Ther. 2017 Mar 13;11:747-757.  

 Chemical & Physical Properties

No Any Chemical & Physical Properties
The content on this webpage is sourced from various professional data sources. If you have any questions or concerns regarding the content, please feel free to contact service1@chemsrc.com.